Ovid Therapeutics (OVID) Cash from Investing Activities Growth (1y) (2017 - 2026)
Ovid Therapeutics (OVID) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ovid Therapeutics |
311.83 Mn |
156.31 Mn |
- |
16.62% |
| Date | Value |
|---|
| Mar 31, 2026 |
16.62% |
| Dec 31, 2025 |
-438.45% |
| Sep 30, 2025 |
1,630.48% |
| Jun 30, 2025 |
-6.00% |
| Mar 31, 2025 |
-74.73% |
| Dec 31, 2024 |
143.89% |
| Sep 30, 2024 |
106.70% |
| Jun 30, 2024 |
-36.10% |
| Mar 31, 2024 |
-33.22% |
| Dec 31, 2023 |
-1,063.59% |
| Sep 30, 2023 |
-122.41% |
| Jun 30, 2023 |
124.87% |
| Mar 31, 2023 |
2,908.96% |
| Dec 31, 2022 |
-2,474.44% |
| Sep 30, 2022 |
-2,961.38% |
| Jun 30, 2022 |
-4,993.60% |
| Mar 31, 2022 |
-9,246.58% |
| Dec 31, 2021 |
-79.00% |
| Sep 30, 2021 |
-67.17% |
| Jun 30, 2021 |
-105.12% |
